Co-trimoxazole for the treatment of serious infections.
D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002006:Brucellosis / Q000188:drug therapy; D002353:Carrier State / Q000188:drug therapy; D004338:Drug Combinations; D006801:Humans; D007410:Intestinal Diseases / Q000188:drug therapy; D008297:Male; D009503:Neutropenia / Q000150:complications; D011472:Prostatitis / Q000188:drug therapy; D011528:Protozoan Infections / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014435:Typhoid Fever / Q000188:drug therapy
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole